Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Unified Protocol treatment for emotional disorders (HiTOP-PRO)

Official title: Investigating the Impact of the Unified Protocol on HiTOP Dimensions and Temperamental Traits in Patients With Emotional Disorders

Run by National Institute of Mental Health, Czech Republic · NCT07557017 · Data updated 2026-11-12

This project will test whether the Unified Protocol—a transdiagnostic cognitive-behavioral therapy—helps adults with emotional disorders feel better than usual care or being on a waitlist.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment90 (estimated)
SponsorNational Institute of Mental Health, Czech Republic
Academic / other
Locations1 site (Prague)
StatusRecruiting
StartedOctober 8, 2025
Main results expectedApril 30, 2028
Study endsJuly 31, 2028
Registry record updatedApril 29, 2026
Trial IDNCT07557017 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18–65 seeking outpatient treatment at NÚDZ who meet ADIS-5 diagnostic criteria for specified emotional disorder categories, can complete Czech-language assessments, and have stable psychotropic medication doses when applicable are ideal candidates.

Probably not a fit

People with a current or lifetime psychotic disorder, a current manic/hypomanic episode, or high acute suicide/self-harm risk requiring higher-level care are excluded and unlikely to benefit from this outpatient psychotherapy protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-site, randomized, parallel-group trial at the National Institute of Mental Health (NÚDZ) in Prague comparing the manualised Unified Protocol (UP) to treatment as usual (TAU) and a waitlist (WL). Adults seeking outpatient care are screened by telephone and diagnostic eligibility is confirmed with the ADIS-5, then randomized 1:1:1 to UP, TAU, or WL. Outcomes focused on HiTOP-aligned dimensional symptom measures and temperamental/personality traits are collected at baseline and approximately 14 weeks post-randomization, with an optional ~3-month follow-up only in the UP arm. Recruitment is rolling and dependent on clinic throughput and therapist availability.

Why it matters

Potential benefit: If successful, UP could reduce broad dimensional symptoms across emotional disorders and improve related temperamental or personality traits, making one structured treatment useful for multiple diagnoses.

How similar studies have gone: The Unified Protocol has prior randomized-trial evidence showing efficacy across anxiety and depressive disorders, but applying HiTOP-aligned dimensional outcomes and conducting this comparison in routine Czech outpatient care is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria: Adults aged 18-65 years.

Seeking outpatient treatment at NÚDZ for emotional disorder symptoms.

Meets diagnostic eligibility on ADIS-5 for at least one of the following (ICD-10 categories consistent with the protocol): F32, F33, F34, F40, F41, F42, F43, F45, F60, F61.

Able to understand and complete study questionnaires and procedures (Czech language).

Willing and able to participate in psychotherapy and complete assessments at baseline and post-treatment (14 weeks).

If taking psychotropic medication: dose stable for ≥6 weeks prior to enrolment and expected to remain stable during the acute study period where clinically feasible.

Provides written informed consent.

Exclusion Criteria: Current or lifetime psychotic disorder or current manic/hypomanic episode.

High acute suicide risk requiring a higher level of care (e.g., imminent risk, recent serious attempt) or current severe self-harm risk incompatible with outpatient psychotherapy study procedures.

Primary substance use disorder requiring specialised treatment or acute intoxication/withdrawal.

Severe cognitive impairment or neurodevelopmental/neurological condition that prevents valid consent or completion of study procedures.

Concurrent psychological treatment that would conflict with study participation (e.g., starting a new structured psychotherapy during the 14-week study period), unless it constitutes the assigned TAU.

Immediate need for intensive treatment (e.g., inpatient admission) at the time of screening.

Inability to commit to the study schedule or complete required assessments.

Where it's running

  • National Institute of Mental healh
    Prague, Czechia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.